[Time course of disappearance of Helicobacter pylori after topical therapy and new triple therapy].
Wang
X M
XM
Department of Gastroenterology, Jichi Medical School.
Taniguchi
Y
Y
Nishifuku
K
K
Kidaira
K
K
Sato
K
K
Sohara
H
H
Kawada
H
H
Kimura
K
K
Kajiwara
M
M
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005756:Gastritis / Q000382:microbiology*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D064747:Lansoprazole; D008795:Metronidazole / Q000008:administration & dosage*; D009853:Omeprazole / Q000008:administration & dosage / Q000031:analogs & derivatives*; D013997:Time Factors
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D064747:Lansoprazole; D008795:Metronidazole; D017291:Clarithromycin; D009853:Omeprazole